Insight Molecular Diagnostics Stock Price, News & Analysis
IMDX
NASDAQ
Company Description
Welcome to the overview page for Insight Molecular Diagnostics (IMDX), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$7.18
-3.49%
0.26
Last updated: January 12, 2026 at 10:30
135.44 %
Performance 1 year
$213.3M
28.7M
Latest News
SEC Filings
Financial Highlights
$518,000
Revenue (TTM)
-$9,742,000
Net Income (TTM)
-$0.30
-$6,279,000
Operating Cash Flow
-1,880.70%
-1,900.00%
Upcoming Events
JAN
12
January 12, 2026
Marketing
LifeSci Advisors access event
The Beacon Grand, San Francisco. One-on-one meetings; schedule via LifeSci Partners.
JAN
12
January 12, 2026 - January 14, 2026
Marketing
JPM Week investor meetings
One-on-one investor meetings in San Francisco during JPM Week; schedule via company contacts.
FEB
09
February 9, 2026 - February 11, 2026
Marketing
BTIG Snowbird meetings
Cliff Lodge, Snowbird, Utah. One-on-one meetings; schedule via BTIG sales representatives.
MAY
01
May 1, 2026 - August 31, 2026
Product
Product launch
Anticipated launch of GraftAssureDx in mid-2026
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Insight Molecular Diagnostics (IMDX)?
The current stock price of Insight Molecular Diagnostics (IMDX) is $7.44 as of January 11, 2026.
What is the market cap of Insight Molecular Diagnostics (IMDX)?
The market cap of Insight Molecular Diagnostics (IMDX) is approximately 213.3M. Learn more about what market capitalization means .
What is the revenue (TTM) of Insight Molecular Diagnostics (IMDX) stock?
The trailing twelve months (TTM) revenue of Insight Molecular Diagnostics (IMDX) is $518,000.
What is the net income of Insight Molecular Diagnostics (IMDX)?
The trailing twelve months (TTM) net income of Insight Molecular Diagnostics (IMDX) is -$9,742,000.
What is the earnings per share (EPS) of Insight Molecular Diagnostics (IMDX)?
The diluted earnings per share (EPS) of Insight Molecular Diagnostics (IMDX) is -$0.30 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Insight Molecular Diagnostics (IMDX)?
The operating cash flow of Insight Molecular Diagnostics (IMDX) is -$6,279,000. Learn about cash flow.
What is the profit margin of Insight Molecular Diagnostics (IMDX)?
The net profit margin of Insight Molecular Diagnostics (IMDX) is -1,880.70%. Learn about profit margins.
What is the operating margin of Insight Molecular Diagnostics (IMDX)?
The operating profit margin of Insight Molecular Diagnostics (IMDX) is -1,900.00%. Learn about operating margins.
What is the gross margin of Insight Molecular Diagnostics (IMDX)?
The gross profit margin of Insight Molecular Diagnostics (IMDX) is 67.57%. Learn about gross margins.
What is the current ratio of Insight Molecular Diagnostics (IMDX)?
The current ratio of Insight Molecular Diagnostics (IMDX) is 4.04, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the gross profit of Insight Molecular Diagnostics (IMDX)?
The gross profit of Insight Molecular Diagnostics (IMDX) is $350,000 on a trailing twelve months (TTM) basis.
What is the operating income of Insight Molecular Diagnostics (IMDX)?
The operating income of Insight Molecular Diagnostics (IMDX) is -$9,842,000. Learn about operating income.